Login / Signup

A methodological pipeline for the preclinical evaluation of novel topical agents for the treatment of CRS.

Samuel J M HaleChristian Albert LuxJames E WilloughbyArne KoefoedDavid BroderickKristi BiswasRaymond KimBrett Wagner MackenzieRichard G Douglas
Published in: International forum of allergy & rhinology (2024)
Novel topical therapeutics require extensive pre-clinical testing to assess efficacy and safety. Antibiofilm or immunosuppressant agents can utilize ex vivo models to measure ciliotoxicity. Agents that are found to be effective and non-toxic ex vivo warrant further investigation in vivo.
Keyphrases
  • small molecule
  • wound healing
  • stem cells
  • replacement therapy
  • smoking cessation